Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.4170
+0.0066 (1.61%)
Dec 22, 2025, 4:00 PM EST - Market closed
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $25.05 million as of December 22, 2025. Its market cap has decreased by -33.65% in one year.
Market Cap
25.05M
Enterprise Value
17.80M
1-Year Change
-33.65%
Ranking
Category
Stock Price
$0.42
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $25.05M, a decrease of -62.06%. That is a compound annual growth rate of -32.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 25.05M | -5.78% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |